Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Surged Today

TheMotleyFool

0 0

Why Moderna Stock Surged TodayPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

Shares of Moderna (NASDAQ: MRNA) jumped 7% on Monday after the biotech released positive data from a key clinical trial for its COVID-19 vaccine, mRNA-1273.

Moderna said interim data from a phase 2/3 study suggested its vaccine demonstrated "a robust neutralizing antibody response" in kids aged 6 to 11 after two 50-microgram doses. Critically, the drug also demonstrated "a favorable safety profile."

The drugmaker intends to submit the trial data to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) "in the near term."

Source Fool.com

Like: 0

MRNA

Share